• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC - GALWAY EXPRESS® LD ILIAC / BILIARY; STENT, ILIAC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC - GALWAY EXPRESS® LD ILIAC / BILIARY; STENT, ILIAC Back to Search Results
Model Number H74938047730130
Medical Device Problem Code Device Dislodged or Dislocated (2923)
Health Effect - Clinical Code No Consequences Or Impact To Patient (2199)
Date of Event 11/08/2016
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Device is a combination product.(b)(4).
 
Event or Problem Description
It was reported that stent dislodgment occurred.The target lesion was located in the left subclavian artery.A 7.0x30x135cm express® ld iliac / biliary stent was advanced to treat the lesion.However, during advancement, the stent came off the balloon.The device was pulled out and the stent was removed with a snare.The procedure was completed with a different device.No patient complications were reported and the patient's status was fine.
 
Additional Manufacturer Narrative
Device evaluated by mfr: the complaint device was returned for analysis.The stent was detached from the balloon.Stent damage was noted along the entire length of the stent with stent struts squashed mostly at one end and mid-section of the stent.The balloon did not appear to have been subjected to any positive pressure.As part of the device analysis, the device was attached to an encore inflation unit and the balloon was inflated to its rated burst pressure with no leaks or restrictions noted.The balloon deflated within 12.5 seconds with no issues noted.A visual and tactile examination identified no issues along the length of the device.No other issues were identified during the product analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The most probable root cause is operational context as device performance was limited due to anatomical procedural factors.(b)(4).
 
Event or Problem Description
It was reported that stent dislodgment occurred.The target lesion was located in the left subclavian artery.A 7.0x30x135cm express® ld iliac / biliary stent was advanced to treat the lesion.However, during advancement, the stent came off the balloon.The device was pulled out and the stent was removed with a snare.The procedure was completed with a different device.No patient complications were reported and the patient's status was fine.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EXPRESS® LD ILIAC / BILIARY
Common Device Name
STENT, ILIAC
Manufacturer (Section D)
BOSTON SCIENTIFIC - GALWAY
MDR Report Key6256010
Report Number2134265-2016-12490
Device Sequence Number1026005
Product Code NIO
UDI-Device Identifier08714729579694
UDI-Public(01)08714729579694(11)20190804(10)0019552977
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
PMA/510(K) Number
P090003
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,health
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 12/19/2016
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date08/04/2019
Device Model NumberH74938047730130
Device Catalogue Number38047-73013
Device Lot Number0019552977
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/30/2016
Type of Report(Section G)FDA Requested
Initial Date Received by Manufacturer 12/19/2016
Supplement Date Received by ManufacturerNot provided
Initial Report FDA Received Date01/17/2017
Supplement Report FDA Received Date02/13/2017
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Required Intervention;
Patient Age56 YR
-
-